Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism SOS1 inhibitors(Son of sevenless homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS mutation-related tumors | Preclinical | US | 06 Jun 2023 |